NCT06890715View on ClinicalTrials.gov

Comparative Pharmacokinetic Study of Ramelteon Modified-Release Tablets and Ramelteon Tablets in Healthy Subjects

PHASE1CompletedINTERVENTIONAL
Enrollment

12

Participants

Timeline

Start Date

June 24, 2024

Primary Completion Date

July 2, 2024

Study Completion Date

July 8, 2024

Conditions
Chronic Insomnia Characterized
Interventions
DRUG

Test product (T): Ramelteon Modified-Release Tablets

Oral, take 1 tablet at a time, once a day.

DRUG

Reference product (R): Ramelteon Tablets

Oral, take 1 tablet at a time, once a day.

Trial Locations (1)

510700

clinical trial centre of Medical ethics committee of Zhujiang Hospital of Southern Medical University, Guangzhou

Sponsors
All Listed Sponsors
collaborator

Beijing CTSmed Co. Ltd

UNKNOWN

lead

Overseas Pharmaceuticals, Ltd.

INDUSTRY

NCT06890715 - Comparative Pharmacokinetic Study of Ramelteon Modified-Release Tablets and Ramelteon Tablets in Healthy Subjects | Biotech Hunter | Biotech Hunter